Adverum Biotechnologies, Inc. Reports Second Quarter 2016 Financial Results
Aug 09, 2016 20:05 pm UTC| Business
MENLO PARK, Calif., Aug. 09, 2016 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a gene therapy company committed to discovering and developing novel medicines for patients suffering from diseases with few or...
OncoMed Pharmaceuticals Reports Second Quarter 2016 Financial Results
Aug 09, 2016 20:05 pm UTC| Business
OncoMed Management to Host Conference Call/Webcast this Afternoon at 4:30 p.m. ET/1:30 p.m. PT REDWOOD CITY, Calif., Aug. 09, 2016 -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing...
SharpSpring Reports Record Second Quarter 2016 Results
Aug 09, 2016 20:05 pm UTC| Business
GAINESVILLE, Fla., Aug. 09, 2016 -- SharpSpring, Inc. (NASDAQ:SHSP), a global provider of cloud-based marketing technologies, reported financial results for the second quarter ended June 30, 2016. Second Quarter 2016...
Everi Reports 2016 Second Quarter Results
Aug 09, 2016 20:05 pm UTC| Business
LAS VEGAS, Aug. 09, 2016 -- Everi Holdings Inc. (NYSE:EVRI) (“Everi” or the “Company”) today reported financial results for the second quarter ended June 30, 2016. Consolidated Full Quarter Comparative Results...
QEP Resources Announces Participation in an Upcoming Investor Conference
Aug 09, 2016 20:05 pm UTC| Business
DENVER, Aug. 09, 2016 -- QEP Resources, Inc. (NYSE:QEP) (“QEP” or the “Company”) announced today that members of the Company’s senior management will participate in the upcoming Enercom Oil Gas Conference on Tuesday,...
Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results
Aug 09, 2016 20:05 pm UTC| Business
Total Revenues of $186.5 MillionAdjusted EPS of $0.36 and Diluted EPS of $0.32Company Issues Fiscal First-Quarter 2017 and Fiscal Year 2017 Financial Guidance SALT LAKE CITY, Aug. 09, 2016 -- Myriad Genetics, Inc....
Aug 09, 2016 20:05 pm UTC| Business
Teijin’s regulatory and commercial infrastructure ideally suited to capitalize on somavaratan, which is positioned to be the first potential long-acting form of recombinant growth hormone (rhGH) to enter the Japanese...